ACVIM small animal consensus statement on lyme disease in dogs: Diagnosis, treatment, and prevention

Journal of Veterinary Internal Medicine

Volumn 20, Issue 2, 2006, Pages 422-434

  Littman, Meryl P ^a   Goldstein, Richard E ^b   Labato, Mary A ^c   Lappin, Michael R ^d   Moore, George E ^e  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c TUFTS UNIVERSITY   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

Arthritis; Borrelia burgdorferi; Glomerulonephritis; Polyarthropathy; Retriever

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; DOXYCYCLINE; LYME DISEASE VACCINE;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTHROPATHY; BLOOD; BORRELIA BURGDORFERI; CONSENSUS DEVELOPMENT; DOG; DOG DISEASE; IMMUNOLOGY; INFESTATION; KIDNEY DISEASE; LYME DISEASE; PRACTICE GUIDELINE; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; DOG DISEASES; DOGS; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; JOINT DISEASES; KIDNEY DISEASES; LYME DISEASE; LYME DISEASE VACCINES; PRACTICE GUIDELINES; TICK INFESTATIONS;

ACARI; ANIMALIA; BORRELIA; BORRELIA BURGDORFERI; CANIS FAMILIARIS; INSECTA;

EID: 33645571011     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[422:ASACSO]2.0.CO;2     Document Type: Review

References (117)

1. Steere AC. Lyme disease. N Engl J Med 2001;345:115-125.
2. Sigal LH. Misconceptions about Lyme disease: Confusions hiding behind ill-chosen terminology. Ann Intern Med 2002;136:413-419.
3. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998;352(9127):557-565.
4. Keirans JE, Hutcheson HJ, Durden LA, Klompen JS. Ixodes (Ixodes) scapularis (Acari:Ixodidae): Redescription of all active stages, distribution, hosts, geographical variation, and medical and veterinary importance. J Med Entomol 1996;33:297-318.
5. Greene CE, Appel MJG, Straubinger RK. Lyme borreliosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. Philadelphia, PA: WB Saunders; 1998:282-293.
6. or Greene CE Straubinger RK. Borreliosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat, 3rd ed. Philadelphia, PA: Elsevier Saunders; 2006:417-435.
7. Badon SJ, Fister RD, Cable RG. Survival of Borrelia burgdorferi in blood products. Transfusion 1989;29:581-583.
8. Chang YF, Straubinger RK, Jacobson RH, et al. Dissemination of Borrelia burgdorferi after experimental infection in dogs. J Spirochetal Tick-Borne Dis 1996;3:80-86.
9. Burgess EC. Natural exposure of Wisconsin dogs to the Lyme disease spirochete (Bb). Lab Anim Sci 1986;36:288-290.
10. Appel MJG, Allen S, Jacobson RH, et al. Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis 1993;167:651-664.
11. Bushmich SL. Lyme disease: Comparative aspects. Proc 18th ACVIM Forum 2000;203-205.
12. Grauer GF, Burgess EC, Cooley AJ, Hagee JH. Renal lesions associated with Borrelia burgdorferi infection in the dog. JAVMA 1988;193:237-239.
13. Post JE, Shaw EE, Wright SD. Suspected borreliosis in cattle. Ann NY Acad Sci 1988;539:488.
14. Lissman BA, Bosler EM, Camay H, et al. Spirochete-associated arthritis (Lyme disease) in a dog. JAVMA 1984;185:219-220.
15. Kornblatt AN, Urband PH, Steere AC. Arthritis caused by Borrelia burgdorferi in dogs. JAVMA 1985;186:960-964.
16. Levy SA, Magnarelli LA. Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. JAVMA 1992;200:344-347.
17. Greene RT, Levine JF, Breitschwerdt EB, et al. Clinical and serologic evaluations of induced Borrelia burgdorferi infection in dogs. Am J Vet Res 1988;49:752-757.
18. Cerri D, Farina R, Andreani E, et al. Experimental infection of dogs with Borrelia burgdorferi. Res Vet Sci 1994;57:256-258.
19. Straubinger RK, Straubinger AF, Summers BA, et al. Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. Wien Klin Wochenschr 1998;110:874-881.
20. Straubinger RK, Straubinger AF, Härter L, et al. Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect Immun 1997;65:1273-1285.
21. Straubinger RK. Summers BA, Chang YF, Appel MJG. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 1997;35:111-116.
22. Straubinger RK, Straubinger AF, Summers BA, Jacobson RH. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study. J Infect Dis 2000;181:1069-1081.
23. Straubinger RK. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J Clin Microbiol 2000;38:2191-2199.
24. Liang FT, Jacobson RH, Straubinger RK, et al. Characterization of a Borrelia burgdorferi VIsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 2000;38:4160-4166.
25. Harter L, Straubinger RK, Summers BA, et al. Upregulation of inducible nitric oxide synthase mRNA in dogs experimentally infected with Borrelia burgdorferi. Vet Immunol Immunopathol 1999;67:271-284.
26. Callister SM, Jobe DA, Schell RF, et al. Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected Ixodes scapularis ticks. J Clin Microbiol 2000;38:3670-3674.
27. Chang YF, Novosel V, Chang CF, et al. Experimental induction of chronic borreliosis in adult dogs exposed to Borrelia hurgdorferi-infected ticks and treated with dexamethasone. Am J Vet Res 2001;62:1104-1112.
28. Straubinger RK, Rao TD, Davidson E, et al. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine. Vaccine 2002;20:181-193.
29. Magnarelli LA, Anderson JF, Schreier AB. Persistence of antibodies to Borrelia burgdorferi in dogs on New York and Connecticut. JAVMA 1990;196:1064-1068.
30. Frank JC. Taking a hard look at Borrelia burgdorferi. JAVMA 1989;194:1521.
31. Magnarelli LA, Anderson JF, Schrier AB, Ficke CM. Clinical and serologic studies of canine borreliosis. JAVMA 1987;191:1089-1094.
32. Rondeau MP, Walton RM, Bissett S, et al. Suppurative, nonseptic polyarthropathy in dogs. J Vet Intern Med 2005;19:654-662.
33. Dambach DM, Smith CA, Lewis RM, Van Winkle TJ. Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987-1992). Vet Pathol 1997;34:85-96.
34. Sanders NA. Canine "Lyme nephritis." Proc. 18th ACVIM Forum 2000:627-628.
35. Levy S. Developing an integrated approach for diagnosing, managing tick-borne diseases. DVM Magazine 2002;June:14-18.
36. Camacho AT, Guitian FJ, Pallas E, et al. Azotemia and mortality among Babesia microti-like infected dogs. J Vet Intern Med 2004;18:141-146.
37. Belongia EA. Epidemiology and impact of coinfections acquired from Ixodes ticks. Vector Borne Zoonotic Dis 2002;2:265-273.
38. Adelson ME, Rao RV, Tilton RC, et al. Prevalence of Borrelia burgdorferi, Bartonella spp, Babesia microti, and Anaplasma phagocytophila in Ixodes scapularis ticks collected in northern New Jersey. J Clin Microbiol 2004;42:2799-2801.
39. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol 1996;34:724-727.
40. Eskow E, Rao RVS, Mordechai E. Concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae: Evidence for a novel tick-borne disease complex. Arch Neurol 2001;58:1357-1363.
41. Thomas V, Anguita J, Barthold SW. Fikrig E. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun 2001;69:3359-337l.
42. Moro MH, Zegarra-Moro OL, Bjornsson J, et al. Increased arthritis severity in mice coinfected with Borrelia burgdorferi and Babesia microti. J Infect Dis 2002;186:428-431.
43. Hopkins RS, Jajosky RA, Hall PA, et al. Summary of notifiable diseases, United States, 2003. MMWR 2005;52(54):1-85. (www.cdc.gov/mmwr/)
44. Richter D, Spielman A, Komar N, Matuschka FR. Competence of American robins as reservoir hosts for Lyme disease spirochetes. Emerg Infect Dis 2000;6:133-138.
45. Gylfe A, Bergstrom S, Lundstrom J, Olsen B. Reactivation of Borrelia infection in birds. Nature 2000;403(6771):724-725.
46. Burgdorfer W, Barbour A, Hayes S, et al. Lyme Disease - A tick-borne spirochetosis? Science 1982;216(18Jun):1317-1319.
47. Persing DH, Rutledge BJ, Rys PN, et al. Target imbalance: Disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis 1994;169:668-672.
48. Kersten A, Poitschek C, Rauch S, Aberer E. Effects of penicillin, cetriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother 1995;39:1127-1133.
49. Gruntar I, Malovrh T, Murgia R, Cinco M. Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo. APMIS 2001;109:383-388.
50. Brorson O, Brorson SH. A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes. APMIS 1998;106:1131-1141.
51. Brorson O, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 1998;26:144-150.
52. Brorson O, Brorson SH. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 1997;25:240-246.
53. Murgia R, Piazzetta C, Cinco M. Cystic forms of Borrelia burgdorferi sensu lato: Induction, development, and the role of RpoS. Wien Klin Wochenschr 2002;114:574-579.
54. Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine. Int Microbiol 2002 Mar;5:25-31.
55. Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. APMIS 1999;107:566-576.
56. Mursic VP, Wanner G, Reinhardt S, et al. Formation and cultivation of Borrelia burgdorferi spheroplast L-form variants. Infection 1996;24:218-226.
57. Littman MP. Canine borreliosis. In: Macintire DK, Breitschwerdt EB, eds. Emerging and Re-emerging Infectious Diseases. Vet Clin North Am Small Anim Pract 2003;33:827-862.
58. Greene RT, Walker RL, Burgess EC, Levine JF. Heterogeneity in immunoblot patterns obtained by using four strains of Borrelia burgdorferi and sera from naturally exposed dogs. J Clin Microbiol 1988;26:2287-2291.
59. Guerra MA, Walker ED, Kitron U. Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure. J Clin Microbiol 2000;38:2628-2632.
60. Bacon RF, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VIsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003;187:1187-1199.
61. Levy S, O'Connor TP, Hanscom JL, Shields P. Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet Ther 2002;3:308-315.
62. Levy S. Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Vet Ther 2002;3:420-424.
63. IDEXX Laboratories, Lyme Quant C6 Test. Available at: www.idexx.com/animalhealth/laboratory/c6/index.jsp. Accessed February 27, 2006.
64. Mogilyansky E, Loa CC, Adelson ME, et al. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin Diagn Lab Immunol 2004;11:924-929.
65. Steere AC. Duration of antibiotic therapy for Lyme disease. Ann Int Med 2003;138:761-762.
66. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. Ann Int Med 2003;138:697-704.
67. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.
68. Philipp MT, Bowers LC, Fawcett PT, et al. Antibody response to IR6, a conserved immunodominant region of the VIsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis 2001;184:870-878.
69. Murgia R, Cinco M. Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS 2004;112:57-62.
70. Alban PS, Johnson PW, Nelson DR. Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology 2000;146:119-127.
71. Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole. Int Microbiol 2004;7:139-142.
72. Murgia R, Piazzetta C, Cinco M. Cystic forms of Borrelia burgdorferi sensu lato: Induction, development, and the role of RpoS. Wien Klin Wochenschr 2002;114:574-579.
73. Fendler C, Laitko S, Sorensen H, et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2001;60:337-343.
74. Yu LP, Smith GN, Brandt KD, et al. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35:1150-1159.
75. Yu LP, Burr DB, Brandt KD, et al. Effects of oral doxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis. J Rheum 1996;23:137-142.
76. Lees GE, Brown SA, Elliott J, et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum consensus statement (small animal). J Vet Intern Med 2005;19:377-385.
77. Straubinger RK, Straubinger AF, Summers BA, et al. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study. J Infect Dis. 2000;181:1069-1081.
78. Peltomaa M, McHugh G, Steere AC. Persistence of the antibody response to the VIsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis 2003;187:1178-1186.
79. Neer TM, Breitschwerdt EB, Greene RT, Lappin MR. Consensus statement of ehrlichial disease of small animals from the infectious disease study group of the ACVIM. J Vet Intern Med 2002;16:309-315.
80. Duncan AW, Correa MT, Levine JF, Breitschwerdt EB. The dog as a sentinel for human infection: Prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states. Vector Borne Zoonotic Dis 2004;4:221-229.
81. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84.
82. Wallich R, Siebers A, Jahraus O, et al. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of Lyme disease. Infect Immun 2001;69:2130-2136.
83. Zhong W, Gern L, Stehle T, et al. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur J Immunol 1999;29:946-957.
84. Appel MJG. Lyme disease in dogs. Suppl Comp Cont Ed 2002;24(1A):19-23.
85. Levy SA, Lissman BA, Ficke CM. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. JAVMA 1993;202:1834-1838.
86. Levy SA, Clark KK, Glickman LT. Infection rates in dogs vaccinated and not vaccinated with an OspA Borrelia burgdorferi vaccine in a Lyme disease-endemic area of Connecticut. Int J Appl Res Vet Med 2005;3:1-5.
87. Conlon JAR, Mather TN, Tanner P, et al. Efficacy of a non-adjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge with ticks naturally infected with Borrelia burgdorferi. Vet Ther 2000;1:96-107.
88. Klingborg DJ, Hustead DR, Curry-Galvin EA, et al. AVMA council on biologic and therapeutic agents' report on cat and dog vaccines. JAVMA 2002;221:1401-1407.
89. Jacobson RH, Chang YF, Shin SJ. Lyme disease: Laboratory diagnosis of infected and vaccinated symptomatic dogs. Semin Vet Med Surg (Small Anim) 1996;11:172-182.
90. Paul MA, Appel M, Barrett R, et al. Report of the AAHA Canine Vaccine Task Force: Executive summary and 2003 canine vaccine guidelines and recommendations. JAAHA 2003;39:119-131.
91. Straubinger RK, Chang YF, Jacobson RH, Appel MJG. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J Clin Microbiol 1995;33:2745-2751.
92. Littman MP. Why I don't use Lyme disease vaccines. Comp Cont Ed 1997;19:1269, 1272, 1274-1275.
93. Littman MP. Immune-mediated reactions against Lyme vaccine. Proc 18th Ann Vet Med Forum, ACVIM 2000:629-630.
94. Guerau-de-Arellano M, Huber BT. Development of autoimmunity in Lyme arthritis. Curr Opin Rheum 2002;14:388-393.
95. Birner P, Gatterbauer B, Drobna D, et al. Molecular mimicry in infectious encephalitis and neuritis: Binding of antibodies against infectious agents on Western blots of human nervous tissue. J Infect 2000;41:32-38.
96. Benvenga S, Guarneri F, Vaccaro M, et al. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid 2004;14:964-966.
97. Steere AC, Gross D, Meyer AL, Huber BT. Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J Autoimmun 2001;16:263-268.
98. Gross DM, Fortshubar T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998;281:703-706.
99. Sigal LH, Williams S, Soltys B, Gupta R. H9724, a monoclonal antibody to Borrelia burgdorferi's flagellin, binds to heat shock protein 60 (HSP60) within live neuroblastoma cells: A potential role for HSP60 in peptide hormone signaling and in an autoimmune pathogenesis of the neuropathy of Lyme disease. Cell Mol Neurobiol 2001;21:477-495.
100. L is a partial agonist for outer surface protein A-reactive T cells. J Immunol 2001;166:5286-5291.
101. Willett TA, Meyer AL, Brown EL, et al. An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc Natl Acad Sci U S A 2004;101:1303-1308.
102. Lim LC, England DM, DuChateau BK, et al. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun 1994;62:2825-2833.
103. Du Chateau BK, England DM, Callister SM, et al. Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters. Infect Immun 1996;64:2540-2547.
104. Hu LT, Klempner MS. Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol 1997;17:354-365.
105. Philipp MT. Studies on OspA: A source of new paradigms in Lyme disease research. Trends Microbiol 1998;6:44-47.
106. Sigal LH. Lyme disease: A review of aspects of its immunology and immunopathogenesis. Ann Rev Immunol 1997;15:63-92.
107. Croke CL, Munson EL, Lovrich SD, et al. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun 2000;68:658-663.
108. Gondolf KB, Mihatsch M, Curschellas E, et al. Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. Arthritis Rheum 1994;37:1070-1077.
109. Westport Weston Health District, Analyze your property. Available at: www.wwhd.org/TLD_CD/anaprop2.htm. Accessed February 27, 2006.
110. Westport Weston Health District, Tick safe zones. Available at: www.wwhd.org/TLD_CD/zones.htm. Accessed February 27, 2006.
111. Stafford III, KC. Tick management handbook. Available at: www.cdc.gov/ncidod/dvbid/lyme/resources/handbook.pdf. Accessed February 27, 2006.
112. desVignes F, Piesman J, Heffernan R, et al. Effect of tick removal on transmission of Borrelia hurgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 2001;183:773-778.
113. Kidd L, Breitschwerdt EB. Transmission times and prevention of tick-borne diseases in dogs. Comp Cont Ed 2003;25:742-750.
114. Elfassy OJ, Goodman FW, Levy SA, Carter LL. Efficacy of an amitraz-impregnated collar in preventing transmission of Borrelia burgdorferi by adult Ixodes scapularis to dogs. JAVMA 2001;219:185-189.
115. Blagburn BL, Spencer JA, Billeter SA, et al. Use of imidacloprid- permethrin to prevent transmission of Anaplasma phagocytophilum from naturally infected Ixodes scapularis ticks to dogs. Vet Ther 2004;5:212-217.
116. Korshus JB, Munderloh UG, Bey RF. et al. Experimental infection of dogs with Borrelia hurgdorferi sensu stricto using Ixodes scapularis ticks artificially infected by capillary feeding. Med Microbiol Immunol (Berl) 2004;193:27-34.
117. Zhong W, Oschmann P, Wellensiek HJ. Detection and preliminary characterization of circulating immune complexes in patients with Lyme disease. Med Microbiol Immunol (Berl) 1997;186:153-158.